(Q34950615)

English

The G-protein coupled estrogen receptor (GPER/GPR30) is a gonadotropin receptor dependent positive prognosticator in ovarian carcinoma patients

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

The G-protein coupled estrogen receptor (GPER/GPR30) is a gonadotropin receptor dependent positive prognosticator in ovarian carcinoma patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

G protein-coupled receptor

0 references

ovarian carcinoma

1 reference

based on heuristic

inferred from title

4

object named as

Klaus Friese

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

author name string

Sabine Heublein

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Doris Mayr

2

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Thomas Vrekoussis

3

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Simone S Hofmann

5

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Udo Jeschke

6

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Miriam Lenhard

7

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

9 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

e71791

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

copyright license

Creative Commons Attribution 4.0 International

9 August 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Inducers of G-protein coupled estrogen receptor (GPER) in endometriosis: potential implications for macrophages and follicle maturation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739730

8 July 2018

Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739730

8 July 2018

Enhanced expression of G-protein coupled estrogen receptor (GPER/GPR30) in lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739730

8 July 2018

Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739730

8 July 2018

GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739730

8 July 2018

Puerarin suppresses proliferation of endometriotic stromal cells partly via the MAPK signaling pathway induced by 17ß-estradiol-BSA

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739730

8 July 2018

Estrogen receptors are found in glia and at extranuclear neuronal sites in the dorsal striatum of female rats: evidence for cholinergic but not dopaminergic colocalization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739730

8 July 2018

The G protein-coupled receptor GPR30 mediates the proliferative and invasive effects induced by hydroxytamoxifen in endometrial cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739730

8 July 2018

The G protein-coupled estrogen receptor 1 (GPER/GPR30) does not predict survival in patients with ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739730

8 July 2018

Human chorionic gonadotropin and its relation to grade, stage and patient survival in ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739730

8 July 2018

Are gonadotrophins tumorigenic--a critical review of clinical and experimental data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739730

8 July 2018

Tamoxifen for relapse of ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739730

8 July 2018

The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739730

8 July 2018

Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739730

8 July 2018

GPR30 predicts poor survival for ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739730

8 July 2018

Estrogen regulation of gene expression in GnRH neurons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739730

8 July 2018

A phase II evaluation of goserelin and bicalutamide in patients with ovarian cancer in second or higher complete clinical disease remission.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739730

8 July 2018

Estrogen receptor {beta}1 exerts antitumoral effects on SK-OV-3 ovarian cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739730

8 July 2018

FSH stimulates ovarian cancer cell growth by action on growth factor variant receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739730

8 July 2018

Estrogen receptor-alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739730

8 July 2018

Phase II trial of tamoxifen and goserelin in recurrent epithelial ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739730

8 July 2018

Overexpression of follicle-stimulating hormone receptor activates oncogenic pathways in preneoplastic ovarian surface epithelial cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739730

8 July 2018

CA125 response is associated with estrogen receptor expression in a phase II trial of letrozole in ovarian cancer: identification of an endocrine-sensitive subgroup.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739730

8 July 2018

A new mathematical model for relative quantification in real-time RT-PCR

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739730

8 July 2018

Ovarian epithelial tumor growth promotion by follicle-stimulating hormone and inhibition of the effect by luteinizing hormone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739730

8 July 2018

Ras-dependent activation of MAP kinase pathway mediated by G-protein beta gamma subunits.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739730

8 July 2018

Direct evidence that Gi-coupled receptor stimulation of mitogen-activated protein kinase is mediated by G beta gamma activation of p21ras

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3739730

8 July 2018

Potentiation of GPCR-signaling via membrane targeting of G protein alpha subunits

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071791

21 January 2018

Follicle stimulating hormone-induced growth promotion and gene expression profiles on ovarian surface epithelial cells.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071791

21 January 2018

Induction of G protein-coupled estrogen receptor (GPER) and nuclear steroid hormone receptors by gonadotropins in human granulosa cells

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071791

21 January 2018

The G-protein-coupled estrogen receptor (GPER) is expressed in normal human ovaries and is upregulated in ovarian endometriosis and pelvic inflammatory disease involving the ovary

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071791

21 January 2018

Decreased luteinizing hormone receptor mRNA expression in human ovarian epithelial cancer.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071791

21 January 2018

Differential regulation of two forms of gonadotropin-releasing hormone messenger ribonucleic acid by gonadotropins in human immortalized ovarian surface epithelium and ovarian cancer cells.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071791

21 January 2018

A phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0071791

21 January 2018

Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23951246

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy of tamoxifen in patients with advanced epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23951246

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/23951246

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]

1 reference

https://pubmed.ncbi.nlm.nih.gov/23951246

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Opposed roles of follicle-stimulating hormone and luteinizing hormone receptors in ovarian cancer survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/23951246

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/23951246

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of primary breast cancer with chemotherapy and tamoxifen

1 reference

https://pubmed.ncbi.nlm.nih.gov/23951246

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gefitinib in combination with tamoxifen in patients with ovarian cancer refractory or resistant to platinum-taxane based therapy--a phase II trial of the AGO Ovarian Cancer Study Group (AGO-OVAR 2.6)

1 reference

https://pubmed.ncbi.nlm.nih.gov/23951246

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and Goserelin

1 reference

https://pubmed.ncbi.nlm.nih.gov/23951246

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0071791

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

2013PLoSO...871791H

0 references

release_atnn25o23jh5fpxqzzmqknno5e

1 reference

https://api.fatcat.wiki/v0/release/atnn25o23jh5fpxqzzmqknno5e

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34950615&oldid=1864254112"